Modified FOLFIRINOX in pancreatic cancer patients Age 75 or older

Mizrahi, JD; Rogers, JE; Hess, KR; Wolff, RA; Varadhachary, GR; Javle, MM; Shroff, RT; Ho, L; Fogelman, DR; Raghav, KPS; Overman, MJ; Pant, S

Mizrahi, JD (corresponding author), 1400 Holcombe Blvd Unit 463, Houston, TX 77030 USA.

PANCREATOLOGY, 2020; 20 (3): 501

Abstract

Background: Although FOLFIRINOX (5-Fluorouracil + leucovorin + irinotecan + oxaliplatin) is now the standard of care for patients (pts) with metastati......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索